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(IFN-β) production via the phosphorylation of its C-terminal tail (CTT) by TANK-binding kinase 1 (TBK1). Potent
ligands of STING are, therefore, promising candidates for novel anti-cancer drugs or vaccine adjuvants. However,
the intrinsically ﬂexible CTT poses serious problems in in silico drug discovery. Here, we performedmolecular dy-
namics simulations of the STING fragment containing the CTT in ligand-bound and unbound forms and observed
that the binding of a potent ligand cyclic GMP-AMP (cGAMP) induced a local structure in the CTT, reminiscent of
the known structure of a TBK1 substrate. The subsequent molecular biological experiments conﬁrmed the ob-
served dynamics of the CTT and identiﬁed essential residues for the activation of the IFN-β promoter, leading
us to propose a new mechanism of STING activation.
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cGAMP.1. Introduction
Stimulator of interferon genes (STING) is an essential adaptor pro-
tein in innate immunity, which plays an important role in inducing in-
terferon beta (IFN-β) production when a cell is infected by pathogens
(Ishikawa and Barber, 2008; Ishikawa et al., 2009). In the cytosol, cyclic
GMP-AMP synthase (cGAS) binds to dsDNA derived from pathogen or
host-damaged cells, and produces a small molecule ligand, cyclic
GMP-AMP (cGAMP) (Ablasser et al., 2013; Diner et al., 2013; Sun et
al., 2013). After the binding of cGAMP to STING, STING is phosphorylat-
ed by a SER/THR kinase, TANK-binding kinase 1 (TBK1) (Gao et al.,
2013; Tanaka and Chen, 2012; Zhang et al., 2013). Phosphorylated
STING recruits a transcription factor, interferon regulatory factor 3
(IRF3) and facilitates the phosphorylation of IRF3 by TBK1, which
leads to the dimerization of IRF3 (Larabi et al., 2013; Liu et al., 2015;
Qin et al., 2003; Shu et al., 2013; Tanaka and Chen, 2012). The IRF3
dimer then is translocated to the nucleus and binds to the IFN-β pro-
moter, resulting in its production (Tanaka and Chen, 2012). Small com-
pounds that can bind to STING, therefore, are promising candidates for
anti-cancer drugs or vaccine adjuvants.a, Osaka 565-0871, Japan.
Osaka 567-0085, Japan.
uchiya), kenishii@nibiohn.go.jp
a University, Suita, Osaka 565-
. This is an open access article underSTING consists of 379 residues and forms a homo-dimer. STING is di-
vided into three parts, an N-terminal domain that includes four trans-
membrane regions (1–154), a dimerization and ligand-binding
domain (155–342), and a C-terminal tail (CTT, 343–379) that includes
residues phosphorylated by TBK1. More than 20 crystal structures of
mouse and human STING have been determined to date. These struc-
tures include complex structures with cGAMP and cyclic-di-GMP (c-
di-GMP). The latter is also a natural ligand and shows lower activity
for IFN-β production than cGAMP. All of the known STING structures
contain only the dimerization and ligand binding domain, probably
due to the structural ﬂexibility of the N- and C-terminal domains (Gao
et al., 2013; Zhang et al., 2013). These structures show that ligand bind-
ing leads to a conformational change in a segment (224–244, hereafter
referred to as the Lid) proximal to the ligand-binding site (Huang et al.,
2012; Zhang et al., 2013). In the ligand-bound structures, the Lid seg-
ment from each subunit form a closed conformation by forming a β-
hairpin and putting the two β-hairpin together to form a four-stranded
antiparallel β-sheet. This β-sheet covers the ligand-binding pocket lo-
cated in the interface of the two subunits, hence the name “lid”. On
the other hand, in the ligand-unbound form, the Lid has an open confor-
mation and the ligand-binding site is exposed to the solvent. In c-di-
GMP bound human STING, however, four of the ﬁve crystal structures
have open Lid conformations, suggesting that low-activity ligands can-
not fully maintain the closed Lid conformation (Huang et al., 2012).
The small-molecule compound 5,6-dimethylxanthenone-4-acetic acid
(DMXAA) has been shown to bind and activate mouse, but not
human, STING (Gao et al., 2013). Gao et al. (2014) have demonstratedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ing of DMXAA and the activation of IFN-β production. This mutation in-
duces the closed-Lid conformation, even with the supposedly low
afﬁnity of DMXAA for human STING, suggesting that the closure of the
Lid by ligand binding is essential for IFN-β activity.
Molecular features of STING have been investigated by many re-
search groups, and a number of amino acid residues implicated for
STING function have been identiﬁed. Those residues include phospho-
sites to induce the activation of the IFN-β promoter (Konno et al.,
2013; Tanaka and Chen, 2012; Zhong et al., 2008); multiple studies
using molecular biological techniques have identiﬁed both common
and unique amino acids, such as S324, S326, S358 and S366 in human
STING, to be phosphorylated on STING activation. In addition, genetic
approaches with human SNP analysis or genome analysis of
goldenticket mice have identiﬁed other amino acid residues important
for ligand binding (Sauer et al., 2011). However, no correlation has
been established so far between the IFN-β inducing activity of a ligand
and its binding afﬁnity (Gao et al., 2013). One possible explanation is
the differences in the ability of these ligands to induce structural chang-
es in STING. For example, changes in the dynamics of the CTT may lead
to the phosphorylation of SER and THR residues by TBK1.
In the current work, we adopted an interdisciplinary approach and
predicted the dynamics of STING-CTT by in silico simulations, followed
by the characterization of candidate residues by molecular biological
techniques. We ﬁrst constructed a structural model of the CTT in
human STING and performed molecular dynamics (MD) simulations
in ligand-bound and unbound forms. The simulation of cGAMP-bound
human STING-CTT showed a behavior completely different from those
in the c-di-GMP-bound and ligand-unbound forms. Site-directed muta-
genesis studies, designed based on these observations, elucidated a
phosphosite S354 inmouse (S355 in human) and three residues impor-
tant for STING function, L362, L363 andM223 inmouse (L363, L364, and
K224 in human, respectively), all of which have not been reported be-
fore. Our results suggest that a combination of computer simulations
and molecular biological analysis is a powerful approach to investigat-
ing complex molecular features.
2. Materials and Methods
2.1. Computation
2.1.1. The Construction of STING-CTT Models and the Execution of MD
Simulations
We constructed a structural model of the CTT manually by using
SYBYL-X (Tripos International, 1699), and performed energy minimiza-
tion (50,000 steps), equilibration (500 ps NVT and NPT) and short MD
simulation (3 ns) at 300 K in the cubic box (protein + 1.0 nm) ﬁlled
with tip3p solvents, using the amber99sb force ﬁeld by Gromacs 4.6.2
(Abraham et al., 2015) on Fujitsu PRIMEHPC FX10. The structurally sta-
bilized CTT model was added to the end of both subunits in crystal
structures of human STING (PDBIDs 4ksy, 4f5d and 4f5e). We per-
formed energy minimization (50,000 steps) and equilibration (1 ns)
of the model of STING with the CTT (STING-CTT), where the topologies
of ligands were calculated by using amber12 antechamber (Wang et al.,
2006; Wang et al., 2004). The structurally stabilized STING-CTT models
were used as the initial structures of threeMD simulations, as described
in Results. TheMD simulations of STING-CTTmodels were performed at
300 K for 700 ns in the same conditions as described above. TheFig. 1. The results of theMD simulations of STING-CTT. a) Snapshots at the end of the following t
GMP-bound form (700 ns) and 3) ligand-unbound form (700 ns). The Lid and the CTT are col
movement. The ligands cGAMP and c-di-GMP are shown in ball and stick model. b) The obs
sheet are formed between main-chain atoms in T348 and L364 and those in A350 and E362,
lines. The conserved SERs in mouse and human STING are underlined, where putative phosph
of IRF3 (PDBID 3a77). The SER-rich region that contains phosphosites around the β-sheet is co
by green lines. Blue colored residues are identiﬁed as phosphosites by several experiment
putative phosphosites in STING-CTT are underlined.simulation of the cGAMP-bound form was extended to 1 μs, to observe
the formation and stability of the local structure in the CTT.
2.1.2. Calculation of Electrostatic Potential on Molecular Surfaces
The electrostatic potential on the molecular surfaces of proteins and
ligandswere calculated by SCB (Nakamura and Nishida, 1987). The pro-
gram assigns an electrostatic potential value to each vertex of triangles
that construct a molecular surface calculated by the program MSP
(Connolly, 1983). All the ﬁgures were drawn by the interactive molecu-
lar viewer jV (Kinoshita and Nakamura, 2004).
2.1.3. Calculation of Hydrophobic Interactions
The hydrophobic interactions involving L374 were estimated at
every 50 ns from the interaction network calculated by RINerator
(Doncheva et al., 2011), where the programs Reduce (Word et al.,
1999b) and Probe (Word et al., 1999a) are implemented.
2.2. Experiments
2.2.1. Cell Culture
HEK293were purchased from the American Type Culture Collection
(ATCC), and were maintained in DMEM supplemented with FCS and
50 mg/ml each of penicillin and streptomycin. The sting knockout
MEFs and its counterpartMEFs were kindly gifted by G. Barber (Univer-
sity of Miami Miller School of Medicine). All MEFs used in this study
were maintained in DMEM supplemented with FCS and 50 mg/ml
each of penicillin and streptomycin.
2.2.2. Plasmids Construction
STING expression plasmids were generated by PCR ampliﬁcation
with template of a mouse spleen cDNA library. The cDNA fragments
were introduced into pCIneo (Promega) with HA-tag at the carboxyl
terminus. The expression plasmids of STING point mutants were con-
structed as shown previously (Jounai et al., 2007).
2.2.3. Generation of Stably Transformed MEFs
Recombinant lentiviruses expressing STING or STING mutants were
generated by transfection with pCAG-HIVgp, pCMV-VSV-G-RSV-Rev.
and either CS-STING-IRES-puro or other CS-based expression plasmids
into HEK293 cells. Forty-eight to seventy-two hours following transfec-
tion, the culture supernatants containing recombinant lentiviruseswere
recovered, and transferred to the fresh MEFs. The MEFs expressing
STING or various STINGmutants were selected in the presence of puro-
mycin (2 mg/ml).
2.2.4. Luciferase Assay
HEK293 cells seeded on 24-well plates (2 × 105 cells/well) were
transiently transfected with 25 ng of ﬁreﬂy luciferase reporter plasmid
encoding IFN-β promoter, 25 ng of Renilla luciferase plasmid, and
450 ng of expression plasmid forwild type of STING or STING pointmu-
tants. Forty-eight hours later from transfection, the luciferase expres-
sion level was measured with the Dual-luciferase Reporter Assay
System (Promega, Madison, WI). The ﬁreﬂy luciferase activity was nor-
malized to Renilla luciferase activity in each sample.
2.2.5. Immunoprecipitation and Immunoblotting
Immunoprecipitation and immunoblotting analyses were per-
formed using anti-phosphorylated SER/THR (Cell signaling technology),hreeMD simulations, 1) cGAMP-bound human STING-CTT (simulation time: 1 μs), 2) c-di-
ored blue and red, respectively, where the CTT of the right subunit showed a remarkable
erved CTT structure in the cGAMP-bound form at 780 ns. The hydrogen bonds in the β-
which were estimated by HBPLUS (McDonald and Thornton, 1994) and shown by green
osites are colored blue. c) The structure of the SER-rich region in the recognition domain
lored cyan, where hydrogen bonds between main-chain atoms in the β-sheet are shown
al studies (Lin et al., 1998; Yoneyama et al., 1998). The residues corresponding to the
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Fig. 3. Identiﬁcation of amino acids in STING required for the activation of IFN-β promoter. a–d) IFN-β promoter activities. HEK293 cells were co-transfectedwith pIFN-β Luc, pRG-TK and
indicated plasmids. Forty-eight hours post-transfection, the reporter assay was performed. The expression levels of Renilla luciferase were used as the internal control. The experiments
were performed twice, and representative ﬁgures were shown. The data were expressed as means from duplicates.
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ing technology), or anti-HA (Roche Diagnostics) antibodies, as de-
scribed previously (Jounai et al., 2007). To observe STING
phosphorylation in immunoblotting, 7.5% poly-acrylamide gel was pre-
pared. For evaluating the STING expression levels in the luciferase assay,
NuPAGE gradient gel (4–12%, Thermo Fisher Scientiﬁc) was used.
2.2.6. In vitro Kination Assay
HA-tagged STING (STING-HA) was immunoprecipitated from MEFs
stably expressing STING-HA with an anti-HA antibody (COVANCE).
STING-HA substrates were mixed with TBK1 kinase (MILLIPORE) in
the phosphorylation buffer (20 mM HEPES buffer (pH 7.4) with
100 mM NaCl, 0.1% NP-40, 10% glycerol, 5 mM MgCl2, 5 mM MnCl2,
20mM β-glycerophosphate, and 100 μMNa3VO4) on ice. Some samples
were additionally mixed with 100 μM ATP with/without 50 nMFig. 2. Experimental veriﬁcation of the simulation results. a) A schematic representation of
transfected with pIFN-β Luc, pRG-TK and indicated plasmids. Forty-eight hours post-transfec
used as internal control. The bottom image shows expression levels of STING-HA by imm
representative ﬁgure was shown. The data were expressed the means ± SD from triplicate
dsRNA or dsDNA for 3 h, and then immunoprecipitation and/or immunoblotting analyses w
expressing HA-tagged STING, were stimulated with indicated stimuli for 3 h, and then immu
MEFs stably expressing HA-tagged STING, and precipitates were subjected to an in vitro kinatiostaurosporine (Calbiochem). The kination reaction was performed at
30 °C for 20 min, and immunoblotting was performed immediately.
3. Results
3.1. MD Simulations of Human STING-CTT
Wegenerated a random structure as amodel of the CTT and attached
it to the C-terminal end of both subunits in selected crystal structures of
human STING (see Materials and Methods for details. These structures
are herein referred to as STING-CTTs). The energy-minimized STING-
CTTs were used as the initial structures of three MD simulations (Sup-
plementary Fig. S1a, see Materials and Methods): 1) cGAMP-bound, 2)
c-di-GMP-bound and 3) ligand-unbound forms (with simulation times
of 1 μs, 700 ns and 700 ns, respectively). Snapshots at the end of thethe STING point mutants generated. b) IFN-β promoter activity. HEK293 cells were co-
tion, the reporter assay was performed. The expression levels of Renilla luciferase were
unoblotting with an anti-HA antibody. The experiments were performed twice, and
s. c–e) The sting KO MEFs stably expressing point mutants of STING were treated with
ere performed with the antibodies indicated. f) The tbk1/ikke WT or DKO MEFs, stably
noblotting was performed. g) HA-tagged STING was immunoprecipitated from sting KO
n assay.
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GMP-bound and ligand-unbound forms produced stable but open Lid
structures with no major movements of the CTTs after about 300 ns,
while the cGAMP-bound form produced stable structures after 600 ns
(Supplementary Fig. S1c). We will describe three major observations
from the simulations below.
3.1.1. The cGAMP-bound Form Maintained the Closed Lid Conformation
The Lid retained the closed form in the cGAMP-bound form through-
out the simulation, while it became open in the c-di-GMP-bound form
even though the initial structure had a closed Lid conformation (Fig.
1a, where the Lid structures are colored blue). In the c-di-GMP-bound
form, the Lid started to open at around 30 ns and the distance between
the Lid regions in both subunits increased to about 2.5 times the initial
length (Supplementary Fig. S2a). These observations indicate that only
cGAMP has the ability to maintain the closed Lid conformation.
3.1.2. The End of the CTT Moved Onto the Lid in the Ligand-bound Forms
The end of the CTT moved onto the Lid and stayed there in the li-
gand-bound forms, while it kept away from the center of the Lid in
the ligand-unbound form (Fig. 1a, where the CTT structures are colored
red). We quantiﬁed this observation by the number of CTT atoms in
contact with at least one atom in the Lid from either subunit, where
the contacting atoms were deﬁned to be within 6.0 Å of each other
(Supplementary Fig. S2b). In all three simulations, the CTT from one
subunit (the right subunit in Fig. 1a) came closer to the Lid and stayed
there. We will describe only these CTTs hereafter. In the ligand-boundFig. 4. The electrostatic properties on the Lid. a) The electrostatic potential on the molecular s
human STING (4ksy), and c) that in cGAMP-bound mouse STING (4loj). The molecular surface
the structures on the left, where the Lid is colored blue). The electrostatically negative and p
yellow. The region colored orange or green shows hydrophobic and electrostatically negative oforms, the “right” CTT atoms (in subunit B) frequently contacted both
the “right” and “left” Lid atoms (subunits B and A, respectively) after
the movement of the end of the CTT onto the Lid (around 29 ns and
38 ns in the cGAMP- and c-di-GMP-bound forms, respectively). On the
other hand, in the ligand-unbound form, the “right” CTT atoms (subunit
B) started to approach the Lid from the other direction and started
contacting only the “left” Lid (subunit A) after 250 ns (Fig. 1a and Sup-
plementary Fig. S2b). Thus, only in the ligand-bound forms, the end of
the CTT can cover the entire portion of the Lid.3.1.3. A Local Structure in the CTT was Formed Only in the cGAMP Bound
Form
Only in the cGAMP-bound form, a β-sheet was formed in the CTT
(Fig. 1b). The β-sheet was formed between regions 348–350 and 362–
364, because of the formation of hydrogen bonds between the main-
chain atoms of residues 348 and 364 and those between residues 350
and 362. The β-sheet was formed at around 547 ns, and it was not bro-
ken until the end of the simulation. The prediction of disordered regions
(Shimizu et al., 2007) and secondary structures (Jones, 1999) showed
partial order and β-structures with moderate conﬁdence around the
β-sheet observed in the simulation (Supplementary Fig. S2c), which
supports the simulation result. Note that the transient secondary struc-
ture formation during theMD simulation is compatiblewith no electron
densities observed for the CTT in the existing crystal structures; only
those structures stable for the time-scale of crystallographic analysis
should be visible.urface of the Lid in ligand-unbound human STING (PDBID 4f5e), b) that in cGAMP-bound
s of the Lid are superimposed onto the respective known structures (that are identical to
ositive regions are colored red and blue, respectively. The hydrophobic region is colored
r hydrophobic and electrostatically positive, respectively.
93Y. Tsuchiya et al. / EBioMedicine 9 (2016) 87–96TBK1 also phosphorylates IRF3 in a SER-rich region of its recognition
domain (Lin et al., 1998; Yoneyama et al., 1998).We compared the local
structure observed in STING-CTT to the crystal structure of the SER-rich
region in IRF3 and found that the known phosphorylated SER residues
were placed in similar positions with respect to the β-sheet (Fig. 1c).
These observations suggest that the β-sheet in the CTT is an appropriate
conformation for the substrate recognition by TBK1.3.2. Putative Phosphosites in the CTT
There are four SERs and two THRs in the CTT inmouse STING (seven
and four in human STING, respectively), and all the four SERs and two
THRs in mouse are conserved between the two species (Fig. 1b). After
theβ-sheet formation (at 547ns), T348 and S349 formed newhydrogen
bonds with the residues in the regions other than the CTT, while T376
formed hydrogen bonds before the β-sheet formation and retained
them until the end of the simulation (shown as dots in Supplementary
Fig. S2d). The other three SER residues, S355, S358 and S366, formed
no hydrogen bonds after the β-sheet formation and had large accessible
surface areas of the O-γ atoms (Supplementary Fig. S2e), suggesting
that these three SERs have a high possibility to be phosphorylated by
TBK1.Fig. 5.Anchoring the end of the CTT in the cGAMP-bound form. a) Thehydrogenbonds inK347 a
29 ns. These residues and the ligand cGAMP are shown in ball and stickmodel and stickmodel, r
showed a remarkable movement. b) The hydrogen bonds observed in L374 and R375 at 125 ns,
L374 with Y186 in loop1, and P226 and Q227 in the Lid at 50 ns, which were formed after mo3.3. Site-directedMutagenesis Study of Conserved SERs and THRs in the CTT
Previous reports showed that the CTT of STING included several
phosphosites related to its function of sensing cytosolic DNA. Since
our simulation study showed three of the four conserved SERs as candi-
date phosphosites, all the SER and THR residues conserved between
human and mouse were mutated to ALA, and then all point mutants
of mouse STING were expressed in HEK293 cells to evaluate IFN-β pro-
moter activation (Fig. 2a and b). The point mutation at T347, S348 and
T375 (human T348, S349 and T376, respectively) induced the IFN-β
promoter activity comparable to that of the wild type mouse STING
(Fig. 2b). However, the point mutation at S354 (human S355) reduced
IFN-β promoter activity, and that at S357 (human S358) or S365
(human S366) completely abolished the ability to activate the IFN-β
promoter, indicating that S354, S357 and S365 of mouse STING are im-
portant for the activation of the IFN-β promoter (Fig. 2b).
To conﬁrm whether S354, S357 and S365 of mouse STING are actu-
ally phosphorylated in response to intracellular dsDNA, point mutants
of STING were stably expressed into sting knockout murine embryonic
ﬁbroblasts (MEFs), and then those MEFs were stimulated by dsRNA or
dsDNA to observe STING phosphorylation (Fig. 2a and c). Single point
mutations at S354, S357 or S365 showed a slight decrease in STING
phosphorylation (size of nearly 43 kDa) by dsDNA stimulationnd S349,which are involved in themovement of the end of theCTT onto the Lid during28–
espectively. The Lid and the CTT are colored blue and red, respectively, where the right CTT
which anchored the end of the CTT to the Lid. c) The hydrophobic interactions observed in
ving the end of the CTT onto the Lid and retained until the end of the simulation.
94 Y. Tsuchiya et al. / EBioMedicine 9 (2016) 87–96compared with the wild type (Fig. 2c). However, double mutations at
S357 and S365 changed the band mobility of phosphorylated STING
(PM7 in Fig. 2c), and the triple mutation dramatically decreased the
phosphorylated STING bands upon dsDNA stimulation (PM8 in Fig.
2c), suggesting that at least S354, S357 and S365 of mouse STING
(S355, S358 and S366 of human STING) are phosphorylated in response
to cytosolic dsDNA. To prove dsDNA-mediated phosphorylation of
STING, anti-pSER/THR antibodies were used for immunoblotting (Fig.
2d). As expected, bothmouse and human STING showed the STING pro-
tein bands containing phosphorylated SER and THR residues upon
dsDNA stimulation (Fig. 2d).
3.4. The Importance of the Phosphorylation of STING for IRF3 Activation
To evaluate the importance of STING phosphorylation at S355, S358
and S366 for IRF3 phosphorylation, MEFs stably expressing the wild
type or the triple mutant mouse STING were stimulated with dsRNA
or dsDNA, and then immunoblottingwas performed (Fig. 2e). The treat-
ment of dsRNA led to IRF3 phosphorylation in both transformants (Fig.
2e). However, the MEFs with the triple mutant mouse STING showed
decreased ability to phosphorylate IRF3 in response to cytosolic
dsDNA, indicating that STING phosphorylation is essential for IRF3 acti-
vation upon dsDNA stimulation.
3.5. TBK1 Phosphorylates STING Directly in Response to dsDNA Stimulation
To conﬁrmwhether the phosphorylation of STING upon intracellular
dsDNA-sensing is also regulated by TBK1, tbk1/ikke double knockout
MEFs that stably expressed HA-tagged mouse STING were constructed
(Fig. 2f). The treatment with dsDNA, but not LPS or dsRNA, resulted in
the phosphorylation of mouse STING in the tbk1/ikke wild-type MEFs
(Fig. 2f). However, in the tbk1/ikke double knockout MEFs, theFig. 6. A putative mechanism of STING phosphorylation. Based on the simulation results and ex
STING activation upon binding of a potent ligand such as cGAMP; the binding of only a potent
movement and anchoring of the end of the CTT to Lid, which facilitates the formation of a β-s
the phosphorylation of these residues by TBK1. The phosphorylated CTT recruits IRF3 by bin
TBK1. On the other hand, the binding of the low-activity ligand c-di-GMP does not maintain th
local structures are formed in the CTT.phosphorylation of mouse STING in response to dsDNA was abolished
completely. In addition, IRF3 was phosphorylated by stimuli in the
tbk1/ikkewild-typeMEFs but not the tbk1/ikke knockoutMEFs, suggest-
ing that TBK1 is required for the phosphorylation of STING in response
to intracellular dsDNA (Fig. 2f). To demonstrate that TBK1 directly phos-
phorylates mouse STING, an in vitro kination experiment was per-
formed. As shown in Fig. 2g, TBK1 phosphorylated mouse STING in an
ATP dependentmanner, and the addition of staurosporine, a pan-kinase
inhibitor, reduced the phosphorylated STING bands, suggesting that
TBK1 directly phosphorylates STING.3.6. Site-directedMutagenesis Study of the Residues Forming the β-Sheet in
the CTT
We replaced the six residues in mouse STING that corresponded to
the residues forming the β-sheet in human STING-CTTwith PRO to con-
ﬁrm the signiﬁcance of the β-sheet formation. Of these six mutations,
R361P, L362P and L363P in mouse STING almost entirely abolished
the activation of the IFN-β promoter (Fig. 3a). The corresponding
E362, L363 and L364 in human STING were also replaced with PRO,
and L363P and L364P showed a decrease in IFN-β activity (Fig. 3b), sug-
gesting that conserved LEU residues (L362 and L363 of mouse STING,
and L363 and L364 of human STING) are important for IFN-β promoter
activation mediated by STING phosphorylation.
We observed the residues at the end of the CTT, L374 and R375 in
human STING, to be involved in the formation of the β-sheet indirectly
(see Discussions). L373 and R374 in mouse STING correspond to these
two residues in human and they were also mutated to ALA, and the ex-
pression plasmids were subjected to evaluation of IFN-β promoter ac-
tivity. Both point mutants showed a signiﬁcant decrease in IFN-β
promoter activity compared with wild-type STING, conﬁrming theperimental veriﬁcation, we propose that the following sequence of events must occur for
ligand cGAMP leads to the formation of the closed Lid conformation and the subsequent
heet in the CTT. The β-sheet formation presents the conserved SERs to TBK1 and leads to
ding to the recognition domain of IRF3, which facilitates the phosphorylation of IRF3 by
e closed Lid conformation and thus, the end of the CTT is not anchored to the Lid and no
95Y. Tsuchiya et al. / EBioMedicine 9 (2016) 87–96importance of the putative β-sheet formation for STING activation (Fig.
3c).
3.7. Site-directed Mutagenesis Study of a Non-conserved Residue in the Lid
Finally, we wished to identify candidate residues to explain the dif-
ferences in STING activity between mouse and human, because mouse
STING-mediated IFN-β promoter activity is higher than human STING-
mediated one (Fig. 3a and b). Our simulation hinted us a site, in which
a basic residue in human (K224) is replaced with a non-polar one in
mouse (M223), as will be described in detail later (Fig. 4). Interestingly,
human wild-type STING showed lower activity of the IFN-β promoter
than mouse wild-type STING, whereas a human mutant STING
(K224M) showed recovered activity of the IFN-β promoter, suggesting
that a non-polar residue at this position (224 in human and 223 in
mouse) is key to STING function via the CTT movement and IFN-β acti-
vation (Fig. 3d).
4. Discussions
In bothmouse and human STING, ligand binding causes a conforma-
tional change in the Lid, from open to close, and the natural ligands,
cGAMP and c-di-GMP, with their binding afﬁnity to STING, possess the
ability to close the Lid (Huang et al., 2012; Zhang et al., 2013). However,
several experimental studies showed that only cGAMP-bound human
STING had sufﬁciently high IFN-β activity. In our simulation study of
human STING, only the cGAMP-bound STING-CTT maintained the
closed Lid conformation throughout the simulation (Fig. 1a), suggesting
that themaintenance of the closed Lid conformation for a sustained pe-
riod of time is required for the phosphorylation by TBK1 and the pro-
duction of IFN-β.
Only in the ligand-bound forms, the ends of theCTTsmoved onto the
Lid at an early stage of the simulations (during 28–29ns and 37–38ns in
the cGAMP- and c-di-GMP-bound forms, respectively), and stayed on
the Lid throughout the simulations (Fig. 1a), indicating that the confor-
mational change in the Lid by ligand binding affects the behavior of the
CTT. The conformational change in the Lid alters its electrostatic envi-
ronment; it is highly positive in the ligand-unbound form, due to free
K224, R232 and R238 pointing outward (Fig. 4a and see Materials and
Methods for the calculation of the electrostatic potential), while it is
lowly positive in the ligand-bound forms, because K224 is hydrogen-
bonded to other Lid residues, and R232 and R238 interact with the li-
gand, making the positively charged side-chains in the ARG residues
pointing inward (Fig. 4b). It suggests that changes in the electrostatic
environments (weakened positive charges) on the Lid contributed to
the movement of the CTT onto the Lid. The two ARGs above are con-
served in mouse and human STING, while K224 in human corresponds
to M223 in mouse. Therefore, the electrostatic property on the Lid in li-
gand-boundmouse STING isweaker than that in human STING (Fig. 4c).
The site-directedmutagenesis study of K224M in human STING showed
that this mutation enhanced IFN-β production in human STING (Fig.
3d). In general, IFN-β activity is higher in mouse than in human STING
(Fig. 3d), suggesting that the weakening of the positive charges on the
Lid leads to the enhanced IFN-β production. These observations support
the hypothesis that the movement of the end of the CTT onto the Lid
leads to phosphorylation by TBK1.
This movement may be facilitated by the formation of hydrogen
bonds in the CTT as shown in Fig. 5 and Supplementary Fig. S3a. In the
cGAMP-bound form, the hydrogen bonds in L374 and R375 appeared
to have anchored the end of the CTT to the Lid (Fig. 5b and Supplemen-
tary Fig. S3a). L374 is especially important, because no other residue
pairs between the CTT and Lid formed main-chain hydrogen bonds
(Supplementary Fig. S3a), and L374 also formed hydrophobic interac-
tions with several residues in the Lid throughout the simulation (Fig.
5c, see Materials and Methods). These observations suggest that L374
is the main contributor to anchoring the end of the CTT to the Lid. Thesite-directed mutagenesis study showed that L373A and R374A in
mouse STING, corresponding to L374A and R375A in human STING, de-
creased IFN-β production (Fig. 3c), which is consistent with a previous
study (Tanaka and Chen, 2012) showing that S366 and L374 in human
STING are important for IRF3 activation. L374A and R375A cannot
form the above-described hydrophobic interactions and hydrogen
bonds to anchor the CTT, suggesting the important roles of these resi-
dues in IFN-β production. These observations support our hypothesis
that anchoring the endof theCTT to the Lid facilitatedβ-sheet formation
in the CTT. On the other hand, in the c-di-GMP-bound form, the end of
the CTT moved onto the Lid but the end of the CTT continued to move
from side to side on the Lid during the simulation (Supplementary Fig.
S3b); Lid opening led to no continuous formation of hydrogen bonds be-
tween the residues in the Lid and the end of the CTT (Supplementary
Fig. S3c). These observations suggest that without anchoring the end
of the CTT to the Lid, no local structureswere formed in the CTT for a du-
ration sufﬁcient for its phosphorylation. Therefore, we hypothesize that
anchoring the end of the CTT is necessary for the formation of a local
structure in the CTT, such as the β-sheet observed in the cGAMP-
bound form.
Among the six residues involved in the formation of the β-sheet in
the CTT in the cGAMP-bound form, the mutations L363P and L364P in
human STING and the corresponding L362P and L363P in mouse
STING showed a decrease in IFN-β production (Fig. 3a and b). The PRO
replacement is considered to break secondary structures, both α-helix
and β-sheet, suggesting that the break of the β-sheet by the mutation
L363P and L364P results in the decreased IFN-β activity. The secondary
structure prediction in L363P and L364P in human STING showed lower
probability in forming a β-sheet around these PRO residues (Supple-
mentary Fig. S4a) compared to that in the wild type (Supplementary
Fig. S2c). These observations indicate that the formation of a β-sheet
in the CTT is essential for phosphorylation by TBK1 and IFN-β activity.
The phosphorylation of STING by TBK1 is required for the phosphor-
ylation of IRF3, as described above (Fig. 2e), indicating that both STING
and IRF3 are substrates of TBK1. IRF3 consists of two domains, DNA-
binding and recognition domains. The recognition domain contains a
SER-rich region, where several SER and THRs exist and some of them
have been identiﬁed as phosphosites, such as 2S (S385, S386) and 5ST
(S396, S398, S402, T404 and S405) (Lin et al., 1998; Qin et al., 2003;
Yoneyama et al., 1998). The known structures of the recognition domain
of IRF3 form aβ-sheet in the SER-rich region (Fig. 1c), which is similar to
the conformation of the CTT observed in the simulation of the cGAMP-
bound form (Fig. 1b). The putative phosphosites, S355, S358 and S366
in STING-CTT, are located in the positions corresponding to S396, S398
and T404 or S405 in IRF3, respectively. It suggests that the observed
CTT structure adopts a conformation appropriate for phosphorylation
by TBK1.
Phosphorylated STING recruits IRF3 and facilitates the phosphoryla-
tion of IRF3 by TBK1 (Tanaka and Chen, 2012). It has been shown that
the recruitment of IRF3 by phosphorylated STING is through the binding
of STING to an electrostatically positive region in the recognition do-
main of IRF3 (Supplementary Fig. S4b) (Liu et al., 2015). Our results sug-
gest that the phosphorylation of the CTT would create an
electrostatically negative β-sheet (Supplementary Fig. S4c), which
may preferentially bind to the electrostatically positive region in IRF3.
Based on these observations, we speculate that the β-sheet formation
in the CTT leads to the phosphorylation of both STING and IRF3.
In conclusion, our MD simulations of STING-CTT and experimental
veriﬁcation revealed the dynamics of the CTT involved in ligand binding
and phosphorylation. The site-directed mutagenesis studies conﬁrmed
the importance of the formation of the local structure in the CTT, and
further identiﬁed several residues essential for IFN-β activity, such as
K224, L363 and L364. Based on the results obtained in this study, we
propose a putative mechanism of STING phosphorylation upon binding
of a potent ligand as shown in Fig. 6. Structure-based in silico screening
is an attractive strategy for searching for novel STING ligands as
96 Y. Tsuchiya et al. / EBioMedicine 9 (2016) 87–96candidates for anti-cancer drugs or vaccine adjuvants. However,
methods relying solely on the structure of the ligand-binding domain
(without the CTT) may fall short in evaluating the IFN-β activity, be-
cause of the complex relationship between the ligand-binding and
IFN-β activity. We believe that considering the dynamics of the CTT is
essential for a complete understanding of STING function, and plan to
devise a new screening system based on our STING-CTT MD
simulations.
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